OBJECTIVE: To investigate the association between mucosal fibroblast activity and subglottic stenosis (SGS) development. DESIGN: Prospective study of an animal model of SGS. SETTING: Academic research laboratory. SUBJECTS: New Zealand white rabbits were assigned to either the cricothyroidotomy and carbon dioxide laser injury group or the cricothyroidotomy and silver nitrate injury group. Airways were excised for histologic analysis and the establishment of primary fibroblast cultures. Lesions from surgical excision of established SGS and subglottic tissue were used to analyze SGS recurrence. INTERVENTIONS: The subglottis was approached via cricothyroidotomy and was subjected to either carbon dioxide laser or silver nitrate injury before closure. The SGS lesions were excised at 8 to 10 weeks and were used to establish explants for fibroblast culture. The animals underwent recovery for an additional 14 days to follow recurrence of SGS. After 14 days, all the animals were killed humanely, and subglottic tissue was harvested for histologic evaluation. Rates of migration and contraction of SGS and normal airway fibroblasts were assayed using established in vitro methods under basal conditions and with prostaglandin E(2) treatment. MAIN OUTCOME MEASURES: For in vivo studies, injury, healing, and scarring of the mucosa and cartilage were the primary measures. For cultured fibroblast experiments, cellular responses of fibroblasts from normal and stenosed mucosa were compared and contrasted. RESULTS: Mucosal injury resulted in acute fibroplasia and chronic SGS, surgical excision of mature SGS at 8 weeks resulted in rapid recurrence of stenosis, and SGS-derived fibroblasts were relatively refractory to the effects of prostaglandin E(2) on migration and contraction. CONCLUSIONS: Subglottic stenosis represents a fibrotic airway repair process that involves fibroblasts that produce recurrent, excessive scar formation. We suggest that SGS development and recurrence may be partially dictated by altered fibroblast responsiveness to antifibroplastic signals during mucosal repair.
OBJECTIVE: To investigate the association between mucosal fibroblast activity and subglottic stenosis (SGS) development. DESIGN: Prospective study of an animal model of SGS. SETTING: Academic research laboratory. SUBJECTS: New Zealand white rabbits were assigned to either the cricothyroidotomy and carbon dioxidelaser injury group or the cricothyroidotomy and silver nitrate injury group. Airways were excised for histologic analysis and the establishment of primary fibroblast cultures. Lesions from surgical excision of established SGS and subglottic tissue were used to analyze SGS recurrence. INTERVENTIONS: The subglottis was approached via cricothyroidotomy and was subjected to either carbon dioxide laser or silver nitrate injury before closure. The SGS lesions were excised at 8 to 10 weeks and were used to establish explants for fibroblast culture. The animals underwent recovery for an additional 14 days to follow recurrence of SGS. After 14 days, all the animals were killed humanely, and subglottic tissue was harvested for histologic evaluation. Rates of migration and contraction of SGS and normal airway fibroblasts were assayed using established in vitro methods under basal conditions and with prostaglandin E(2) treatment. MAIN OUTCOME MEASURES: For in vivo studies, injury, healing, and scarring of the mucosa and cartilage were the primary measures. For cultured fibroblast experiments, cellular responses of fibroblasts from normal and stenosed mucosa were compared and contrasted. RESULTS:Mucosal injury resulted in acute fibroplasia and chronic SGS, surgical excision of mature SGS at 8 weeks resulted in rapid recurrence of stenosis, and SGS-derived fibroblasts were relatively refractory to the effects of prostaglandin E(2) on migration and contraction. CONCLUSIONS:Subglottic stenosis represents a fibrotic airway repair process that involves fibroblasts that produce recurrent, excessive scar formation. We suggest that SGS development and recurrence may be partially dictated by altered fibroblast responsiveness to antifibroplastic signals during mucosal repair.
Authors: Vlad C Sandulache; Tripti Singh; Ha Sheng Li-Korotky; Chia Y Lo; Todd D Otteson; Mark Barsic; Joseph E Dohar; Patricia A Hebda Journal: Laryngoscope Date: 2009-07 Impact factor: 3.325
Authors: Diana V Messadi; Hai S Doung; Qhunzhou Zhang; A Paul Kelly; Tai-Lan Tuan; Ernst Reichenberger; Anh D Le Journal: Arch Dermatol Res Date: 2004-07-28 Impact factor: 3.017
Authors: Todd D Otteson; Vlad Constantin Sandulache; Mark Barsic; Gregory M Disilvio; Patricia A Hebda; Joseph E Dohar Journal: Arch Otolaryngol Head Neck Surg Date: 2008-07
Authors: Garret Ma; Idris Samad; Kevin Motz; Linda X Yin; Madhavi V Duvvuri; Dacheng Ding; Daryan R Namba; Jennifer H Elisseeff; Maureen R Horton; Alexander T Hillel Journal: Laryngoscope Date: 2016-09-01 Impact factor: 3.325
Authors: Katsuhide Okunishi; Thomas H Sisson; Steven K Huang; Cory M Hogaboam; Richard H Simon; Marc Peters-Golden Journal: J Biol Chem Date: 2011-07-27 Impact factor: 5.157
Authors: Caitlin Bertelsen; Hagit Shoffel-Havakuk; Karla O'Dell; Michael M Johns; Lindsay S Reder Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-03-01 Impact factor: 6.223
Authors: Kathrine Kronberg Jakobsen; Christian Grønhøj; David H Jensen; Anne Fischer-Nielsen; Thomas Hjuler; Christian von Buchwald Journal: PLoS One Date: 2017-09-21 Impact factor: 3.240